Form 4 Filing for Candel Therapeutics, Inc.

This filing details a Form 4 submission by Candel Therapeutics, Inc. concerning stock options granted to Diem Nguyen, who is a director. On June 23, 2026, 32,000 stock options were granted with a right to buy at a price of $0.00 per share, exercisable upon the earlier of June 23, 2027, or the next Annual Meeting of Stockholders. These options are subject to time-based vesting, with cessation of vesting if the reporting person resigns from the Board of Directors, unless the Board determines otherwise. The underlying security is Common Stock, and the post-transaction ownership stands at 32,000 shares. The option has an expiration date of June 23, 2036, and a conversion or exercise price of $9.08.